X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3562) 3562
Publication (373) 373
Book Review (17) 17
Conference Proceeding (7) 7
Book Chapter (6) 6
Dissertation (5) 5
Data Set (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
osteopontin (2556) 2556
animals (2118) 2118
index medicus (1965) 1965
humans (1637) 1637
male (1153) 1153
mice (965) 965
rats (897) 897
expression (852) 852
female (835) 835
osteopontin - metabolism (822) 822
cells, cultured (738) 738
osteopontin - genetics (675) 675
cell biology (576) 576
gene expression (555) 555
in-vitro (471) 471
proteins (461) 461
differentiation (450) 450
inflammation (429) 429
cell differentiation - drug effects (412) 412
oncology (391) 391
analysis (387) 387
biochemistry & molecular biology (376) 376
sialoglycoproteins - genetics (370) 370
rats, sprague-dawley (361) 361
middle aged (360) 360
biocompatibility (343) 343
osteoblasts - drug effects (342) 342
osteoblasts - metabolism (342) 342
cell line (337) 337
gene-expression (336) 336
rna, messenger - metabolism (327) 327
immunohistochemistry (316) 316
cells (315) 315
collagen (301) 301
adult (299) 299
osteoblasts - cytology (298) 298
research (295) 295
stem cells (292) 292
bone (291) 291
cancer (291) 291
osteogenesis - drug effects (285) 285
biomedical materials (282) 282
alkaline phosphatase - metabolism (279) 279
disease models, animal (275) 275
cell proliferation - drug effects (274) 274
sialoglycoproteins - metabolism (274) 274
medicine (268) 268
endocrinology & metabolism (266) 266
rodents (265) 265
aged (260) 260
apoptosis (260) 260
proliferation (253) 253
research article (252) 252
article (251) 251
mice, inbred c57bl (249) 249
osteoblasts (246) 246
activation (241) 241
time factors (241) 241
growth (240) 240
gene expression regulation - drug effects (239) 239
reverse transcriptase polymerase chain reaction (229) 229
stomatognathic system (229) 229
cell line, tumor (228) 228
signal transduction (228) 228
rna, messenger - genetics (222) 222
metastasis (220) 220
mineralization (219) 219
medicine, research & experimental (215) 215
osteogenesis (213) 213
dose-response relationship, drug (212) 212
immunology (210) 210
multidisciplinary sciences (210) 210
pharmacology & pharmacy (204) 204
up-regulation (204) 204
urology & nephrology (203) 203
cell differentiation (202) 202
cell proliferation (202) 202
osteocalcin (201) 201
rats, wistar (201) 201
materials science, biomaterials (200) 200
disease (197) 197
fibrosis (196) 196
osteocalcin - genetics (196) 196
biomarkers (195) 195
osteocalcin - metabolism (194) 194
messenger-rna (193) 193
cytokines (188) 188
engineering, biomedical (188) 188
physiological aspects (185) 185
genetic aspects (181) 181
health aspects (181) 181
osteopontin - blood (180) 180
protein (178) 178
physiology (174) 174
blotting, western (172) 172
science (170) 170
dentistry (168) 168
mice, knockout (167) 167
dentistry, oral surgery & medicine (164) 164
gene expression - drug effects (164) 164
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3526) 3526
Chinese (37) 37
Czech (1) 1
Hungarian (1) 1
Japanese (1) 1
Persian (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature, ISSN 0028-0836, 08/2010, Volume 466, Issue 7308, pp. 829 - 834
The cellular constituents forming the haematopoietic stem cell (HSC) niche in the bone marrow are unclear, with studies implicating osteoblasts, endothelial... 
PROGENITOR CELLS | OSTEOBLAST | OSTEOPONTIN | MICROENVIRONMENT | MULTIDISCIPLINARY SCIENCES | SELF-RENEWAL | RECEPTOR | DIFFERENTIATION | NEURAL CREST | COOPERATION | EXPRESSION | Chondrocytes - cytology | Nestin | Multipotent Stem Cells - metabolism | Parathyroid Hormone - pharmacology | Cell Lineage - drug effects | Chondrocytes - drug effects | Mesenchymal Stromal Cells - cytology | Multipotent Stem Cells - drug effects | Sympathetic Nervous System - physiology | Cell Division | Stromal Cells - drug effects | Osteoblasts - cytology | Hematopoietic Stem Cells - drug effects | Mesenchymal Stromal Cells - drug effects | Gene Expression Regulation - genetics | Osteoblasts - drug effects | Stromal Cells - metabolism | Cells, Cultured | Mesenchymal Stromal Cells - metabolism | Mice, Transgenic | Hematopoietic Stem Cells - metabolism | Stem Cell Niche - cytology | Nerve Tissue Proteins - metabolism | Granulocyte Colony-Stimulating Factor - pharmacology | Animals | Chemokine CXCL12 - metabolism | Cell Differentiation - drug effects | Multipotent Stem Cells - cytology | Hematopoietic Stem Cells - cytology | Stem Cell Niche - metabolism | Mice | Stem Cell Niche - drug effects | Osteoblasts - metabolism | Intermediate Filament Proteins - metabolism | Mesenchymal Stem Cell Transplantation | Stromal Cells - cytology | Cell Movement | Physiological aspects | Genetic aspects | Research | Bone marrow cells | Gene expression | Osteoblasts | Hematopoietic stem cells | Studies | Proteins | Bone marrow | Rodents | Stem cells
Journal Article
STEM CELLS, ISSN 1066-5099, 11/2006, Volume 24, Issue 11, pp. 2391 - 2397
Journal Article
Journal Article
Journal of Endodontics, ISSN 0099-2399, 2014, Volume 40, Issue 1, pp. 113 - 118
Journal Article
Journal Article
Journal of Dental Research, ISSN 0022-0345, 4/2011, Volume 90, Issue 4, pp. 470 - 476
Journal Article
Journal of Periodontology, ISSN 0022-3492, 11/2010, Volume 81, Issue 11, pp. 1663 - 1674
Journal Article
Journal of Periodontology, ISSN 0022-3492, 08/2009, Volume 80, Issue 8, pp. 1281 - 1288
Background: This study examined the effects of nicotine on osteoblastic differentiation and the osteoclastogenesis regulatory molecules receptor activator of... 
enzymes | periodontal ligament | nicotine | cells | Antioxidant | receptor activator of nuclear factor‐kappa B ligand | Enzymes | Periodontal ligament | Receptor activator of nuclear factor-kappa B ligand | Cells | Nicotine | OXIDATIVE STRESS | HEME OXYGENASE-1 EXPRESSION | INDUCTION | receptor activator of nuclear factor-kappa B ligand | HUMAN GINGIVAL FIBROBLASTS | IN-VITRO | NRF2 | PATHWAY | DENTISTRY, ORAL SURGERY & MEDICINE | BONE | OSTEOCLAST DIFFERENTIATION | TRANSCRIPTION FACTOR | Up-Regulation | Antioxidants - metabolism | Humans | Heme Oxygenase-1 - drug effects | Periodontal Ligament - drug effects | Osteopontin - drug effects | Nicotine - pharmacology | RANK Ligand - drug effects | Periodontal Ligament - cytology | Phosphatidylinositol 3-Kinases - drug effects | Glutathione Peroxidase - drug effects | Nicotinic Agonists - toxicity | Osteoprotegerin - drug effects | Nicotinic Agonists - pharmacology | Ferritins - drug effects | Mitogen-Activated Protein Kinases | Cell Line | Cell Survival - drug effects | Down-Regulation | NF-E2-Related Factor 2 - drug effects | Osteoblasts - drug effects | Nicotine - toxicity | Alkaline Phosphatase - drug effects | Glutamate-Cysteine Ligase - drug effects | Glutathione Transferase - drug effects | NAD(P)H Dehydrogenase (Quinone) - drug effects | Cell Differentiation - drug effects | Osteocalcin - drug effects | Osteoclasts - drug effects | NF-kappa B - drug effects | Index Medicus | Dentistry
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2014, Volume 9, Issue 6, p. e100777
Inhibition of sodium glucose cotransporter 2 (SGLT2) has been reported as a new therapeutic strategy for treating diabetes. However, the effect of SGLT2... 
OXIDATIVE STRESS | ACTIVATION | HYPERGLYCEMIA | SGLT2 INHIBITOR | INFLAMMATION | MULTIDISCIPLINARY SCIENCES | RATS | COMPLICATIONS | MELLITUS | PANCREATIC-FUNCTION | RENAL INJURY | Inflammation - pathology | Oxidative Stress | Kidney Cortex - metabolism | Body Weight - drug effects | Diabetic Nephropathies - drug therapy | Male | Kidney Function Tests | Inflammation - metabolism | Kidney - metabolism | Glomerular Mesangium - metabolism | Glomerular Mesangium - drug effects | Homeostasis - drug effects | Kidney - physiopathology | Disease Models, Animal | Diabetic Nephropathies - pathology | Gene Expression | Glucosides - pharmacology | Kidney Tubules, Proximal - pathology | Kidney - drug effects | Macrophages - pathology | Diabetic Nephropathies - metabolism | Cells, Cultured | Diabetic Nephropathies - genetics | Kidney Cortex - pathology | Sodium-Glucose Transporter 2 - antagonists & inhibitors | Blood Glucose - drug effects | Glomerular Mesangium - pathology | Macrophages - metabolism | Animals | Insulin-Secreting Cells - drug effects | Kidney Tubules, Proximal - metabolism | Glucose - metabolism | Inflammation - genetics | Benzhydryl Compounds - pharmacology | Mice | Apoptosis | Oxidases | Type 2 diabetes | Blood sugar | Analysis | Body weight | Diabetic nephropathies | Hemoglobin | DNA polymerases | Gene expression | Health aspects | Oxidative stress | RNA-directed DNA polymerase | Syngeneic grafts | Homeostasis | Glucose | Macrophages | Blood | NAD(P)H oxidase | Biomedical materials | Hyperglycemia | Rodents | Biocompatibility | Blood pressure | Inhibition | Pancreas | Pharmaceutical sciences | Age | University graduates | Neurochemistry | Creatinine | Kidneys | Cytokines | Diabetes mellitus | Osteopontin | Inflammation | Dentistry | Metabolism | Medicine | Studies | Inhibitors | Nephropathy | Sodium | Monocyte chemoattractant protein | Fibrosis | Infiltration | Diabetes | Monocyte chemoattractant protein 1
Journal Article
Journal Article
Arteriosclerosis, Thrombosis, and Vascular Biology, ISSN 1079-5642, 03/2017, Volume 37, Issue 3, pp. 553 - 566
OBJECTIVE—Sclerostin (SOST) has been identified as an important regulator of bone formation; however, it has not been previously implicated in arterial... 
atherosclerosis | DNA methylation | aortic aneurysm | epigenetics | apolipoprotein E-null mouse | sclerostin | OSTEOPROTEGERIN | BETA-CATENIN | DIFFERENTIAL GENE-EXPRESSION | APOLIPOPROTEIN-E | OSTEOPONTIN | DENSITY-LIPOPROTEIN | PERIPHERAL VASCULAR DISEASE | TRANSFORMING-GROWTH-FACTOR | MATRIX-METALLOPROTEINASE-9 EXPRESSION | HEMATOLOGY | ASSOCIATION | Aortic Aneurysm - metabolism | Apolipoproteins E - deficiency | Muscle, Smooth, Vascular - metabolism | Atherosclerosis - genetics | Humans | Myocytes, Smooth Muscle - pathology | Extracellular Matrix - metabolism | Male | Aorta, Abdominal - drug effects | Aortic Aneurysm - chemically induced | Bone Morphogenetic Proteins - metabolism | Aged, 80 and over | Female | Epigenesis, Genetic - drug effects | Aorta, Abdominal - pathology | Aorta, Thoracic - drug effects | Vascular Remodeling - drug effects | Angiotensin II | Myocytes, Smooth Muscle - drug effects | Aorta, Abdominal - metabolism | Bone Morphogenetic Proteins - genetics | Myocytes, Smooth Muscle - metabolism | Aorta, Thoracic - pathology | Aortic Aneurysm - prevention & control | Muscle, Smooth, Vascular - drug effects | Genetic Predisposition to Disease | Cytokines - metabolism | Atherosclerosis - chemically induced | Mice, Inbred C57BL | Cells, Cultured | Aorta, Thoracic - metabolism | Mice, Transgenic | Atherosclerosis - metabolism | Glycoproteins - administration & dosage | Mice, Knockout | Macrophages - metabolism | Muscle, Smooth, Vascular - pathology | Phenotype | Animals | Wnt Signaling Pathway - drug effects | Apolipoproteins E - genetics | Genetic Markers - genetics | Macrophages - drug effects | Aged | Aortic Aneurysm - genetics | Atherosclerosis - prevention & control | Sclerostin | Abdominal aortic aneurysm
Journal Article
Journal Article